Add Yahoo as a preferred source to see more of our stories on Google. The U.S. Food and Drug Administration has approved elinzanetant, a new non-hormonal treatment to help women manage menopause ...

Add Yahoo as a preferred source to see more of our stories on Google. Even though nearly all women—approximately 85%—report experiencing menopause symptoms, science has offered very few solutions for ...

When people think about breast cancer treatment, they usually picture chemotherapy, radiation, and surgery. But for many of us, treatment doesn’t actually end there. If you’ve been diagnosed with ...

The Food and Drug Administration has approved a new nonhormonal menopause medication to treat hot flashes. Elinzanetant, which was given the green light Friday under the brand name Lynkuet, belongs to ...

Big news in the menopause world: The Food and Drug Administration has just approved the drug elinzanetant as a non-hormonal treatment for hot flashes. The medication, which will be marketed under the ...

GLP-1 medications, such as those with semaglutide, may help you lose weight that’s gained during perimenopause or menopause. They may have an enhanced effect when combined with menopausal hormone ...

WASHINGTON (AP) — Hormone-based drugs used to treat hot flashes and other menopause symptoms will no longer carry a bold warning label about stroke, heart attack, dementia and other serious risks, the ...

WASHINGTON (AP) — Hormone-based drugs used to treat hot flashes and other menopause symptoms will no longer carry a bold warning label about stroke, heart attack, dementia and other serious risks, the ...

Share on Pinterest A combination of hormone therapy and the GLP-1 drug tirzepatide may promote weight loss in postmenopausal females. Image Credit: Mauro Grigollo/Stocksy A new study found that ...

The U.S. Food and Drug Administration has approved a new non-hormonal treatment to help women manage menopause symptoms such as hot flashes and night sweats. Elinzanetant (Lynkuet), a once-daily pill, ...